DENECIMIG
UNII EUV85RR8DJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Denecimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EUV85RR8DJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2488745-86-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

EUV85RR8DJ

CAS Registry Number

2488745-86-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DENECIMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190437

National Cancer Institute reference terminology for clinical and research data.

INN ID

12155

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-208

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Denecimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DENECIMIG

Common Names & Synonyms

DENECIMIG [INN]

DENECIMIG [USAN]

IMMUNOGLOBULIN G4 (230-PROLINE,DE-449-LYSINE), ANTI-(HUMAN BLOOD-COAGULATION FACTOR IX)(HUMAN CLONE 0365-0001-9985 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN CLONE 0365-0001-9985 .KAPPA.-CHAIN, (228->226'),(231->229')-BIS(DISULFIDE) WITH ANTI-(HUMAN BLOOD-COAGULATION FACTOR X) IMMUNOGLOBULIN G4 (228-PROLINE,405-LEUCINE,409-LYSINE,DE-447-LYSINE) (HUMAN CLONE 0365-0001-8174 .GAMMA.4-CHAIN) DISULFIDE WITH HUMAN CLONE 0365-0001-8174 .KAPPA.-CHAIN